Mobile

A multicenter, open-label, randomized, pilot study to evaluate the efficacy and safety of the combination of etanercept (ETN) and methotrexate and of etanercept (ETN) alone in patients with active pla...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-004201-18

A multicenter, open-label, randomized, pilot study to evaluate the efficacy and safety of the combination of etanercept (ETN) and methotrexate and of etanercept (ETN) alone in patients with active plaque psoriasis despite methotrexate therapy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of combined ETN and MTX treatment and of ETN treatment alone as measured by the proportion of patients whose active psoriatic disease is judged to be cleared or almost cleared on the PGA (Physician's Global Assessment of psoriasis) after 24 weeks of treatment.

Critère d'inclusion

  • Plaque psoriasis

Liens